Michael Eberhardson

499 total citations
15 papers, 341 citations indexed

About

Michael Eberhardson is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Michael Eberhardson has authored 15 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Michael Eberhardson's work include Inflammatory Bowel Disease (8 papers), Pancreatic function and diabetes (6 papers) and Microscopic Colitis (5 papers). Michael Eberhardson is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Pancreatic function and diabetes (6 papers) and Microscopic Colitis (5 papers). Michael Eberhardson collaborates with scholars based in Sweden, Germany and United States. Michael Eberhardson's co-authors include Eva Grapengiesser, Peter Bergsten, Per Marits, Ola Winqvist, Per Karlén, Steven Patterson, Fredrik Piehl, Vivianne Malmström, Mats Karlsson and Emma Ahlén Bergman and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and International Journal of Molecular Sciences.

In The Last Decade

Michael Eberhardson

14 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Eberhardson Sweden	10	144	115	113	87	77	15	341
Jessica Bonneau France	8	88 0.6×	96 0.8×	83 0.7×	52 0.6×	52 0.7×	10	314
M. Previti Italy	12	64 0.4×	140 1.2×	141 1.2×	35 0.4×	45 0.6×	18	306
Sonja Vogl Austria	7	163 1.1×	95 0.8×	84 0.7×	36 0.4×	24 0.3×	11	376
Kristofer Thörn Sweden	9	110 0.8×	27 0.2×	168 1.5×	143 1.6×	43 0.6×	11	369
Valentina Capobianco Italy	8	178 1.2×	64 0.6×	100 0.9×	34 0.4×	35 0.5×	9	314
Naruhiro Fujita Japan	10	58 0.4×	115 1.0×	74 0.7×	76 0.9×	54 0.7×	21	293
Mia Ståhle Finland	11	82 0.6×	114 1.0×	37 0.3×	196 2.3×	28 0.4×	25	495
Shibu John United Kingdom	11	199 1.4×	88 0.8×	55 0.5×	44 0.5×	71 0.9×	16	429
Keiichi Hara Japan	13	146 1.0×	56 0.5×	54 0.5×	48 0.6×	24 0.3×	37	349
Masahiko Kutsukake Japan	12	113 0.8×	46 0.4×	34 0.3×	75 0.9×	42 0.5×	17	334

Countries citing papers authored by Michael Eberhardson

Since Specialization

Citations

This map shows the geographic impact of Michael Eberhardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Eberhardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Eberhardson more than expected).

Fields of papers citing papers by Michael Eberhardson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Eberhardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Eberhardson. The network helps show where Michael Eberhardson may publish in the future.

Co-authorship network of co-authors of Michael Eberhardson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Eberhardson. A scholar is included among the top collaborators of Michael Eberhardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Eberhardson. Michael Eberhardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Eberhardson, Michael, et al.. (2025). Impact of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis on Colorectal Cancer Risk: National Cohort Study. Clinical Gastroenterology and Hepatology. 24(2). 503–511.

Marits, Per, Ulf Sundin, Ann–Charlotte Wikström, et al.. (2017). Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment. International Journal of Molecular Sciences. 18(3). 575–575. 19 indexed citations

Fagerberg, Ulrika L., et al.. (2017). Mucosal Cytokine Profiles After Induction Therapy With Granulocyte/Monocyte Apheresis in New‐onset Inflammatory Colitis. Journal of Pediatric Gastroenterology and Nutrition. 66(4). e103–e107. 2 indexed citations

Eberhardson, Michael, Jonas Söderling, Martin Neovius, et al.. (2017). Anti‐TNF treatment in Crohn's disease and risk of bowel resection—a population based cohort study. Alimentary Pharmacology & Therapeutics. 46(6). 589–598. 33 indexed citations

Eriksson, Carl, Sven Almér, Jan Björk, et al.. (2015). Tu1368 Vedolizumab in Inflammatory Bowel Disease, the First Experience From the Swedish IBD Registry (SWIBREG). Gastroenterology. 148(4). S–871. 1 indexed citations

Karlsson, Mats, Maria Lampinen, Per Karlén, et al.. (2013). Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 49(1). 66–74. 8 indexed citations

Lindberg, Annelie, Michael Eberhardson, Mats Karlsson, & Per Karlén. (2010). Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease. BMC Gastroenterology. 10(1). 73–73. 33 indexed citations

Karlsson, Magnus K., K. Lindberg, Per Karlén, et al.. (2010). Evidence for Immunosurveillance in Intestinal Premalignant Lesions. Scandinavian Journal of Immunology. 71(5). 362–368. 17 indexed citations

Janson, Peter, Emma Ahlén Bergman, Per Marits, et al.. (2010). Profiling of CD4+ T Cells with Epigenetic Immune Lineage Analysis. The Journal of Immunology. 186(1). 92–102. 72 indexed citations

10.

Eberhardson, Michael, et al.. (2006). The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes.. Proteome Science. 4(1). 22–22. 51 indexed citations

11.

Gylfe, Erik, Meftun Ahmed, Peter Bergsten, et al.. (2000). Signaling Underlying Pulsatile Insulin Secretion. Upsala Journal of Medical Sciences. 105(2). 35–51. 18 indexed citations

12.

Eberhardson, Michael, Steven Patterson, & Eva Grapengiesser. (2000). Microfluorometric analysis of Cl− permeability and its relation to oscillatory Ca2+ signalling in glucose-stimulated pancreatic β-cells. Cellular Signalling. 12(11-12). 781–786. 35 indexed citations

13.

Eberhardson, Michael & Eva Grapengiesser. (1999). Glucose and tolbutamide trigger transients of Ca2+in single pancreaticβ-cells exposed to tetraethylammonium. Cell Calcium. 25(5). 355–360. 9 indexed citations

14.

Gylfe, Erik, et al.. (1998). Generation of glucose-dependent slow oscillations of cytoplasmic Ca2+ in individual pancreatic beta cells.. PubMed. 24(1). 25–9. 11 indexed citations

15.

Hellman, Bo, Erik Gylfe, Eva Grapengiesser, et al.. (1994). The role of Ca2+ in the release of pancreatic islet hormones.. Diabetes & Metabolism. 20(2). 123–131. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact